Janelle Monaé is making more waves with the release of the second music video from her latest album The Age of Pleasure. She and director Alan Ferguson (who also worked on “Lipstick Lover,” Solange’s “Cranes in the Sky” and Lizzo’s “Good as Hell”) collaborated to bring “Waterslide” to life.
Like “Lipstick Lover,” the video for “Waterslide” is marked by vintage flower-power style and colorful, grainy shots. In the clip, Janelle and a crew party and perform — with her musical collaborator Nate Wonder on the drums — at a lush,...
Like “Lipstick Lover,” the video for “Waterslide” is marked by vintage flower-power style and colorful, grainy shots. In the clip, Janelle and a crew party and perform — with her musical collaborator Nate Wonder on the drums — at a lush,...
- 7/7/2023
- by Mankaprr Conteh
- Rollingstone.com
Mumbai, Jan 3 (Ians) Scientists from Mumbai’s Tata Institute of Fundamental Research (Tifr), the Agharkar Research Institute (Ari) in Pune, and Iit Hyderabad have discovered an alternative drug molecule indicating high antitumor potential on cancer cells with exceptional ability to reduce unwanted growth of blood vessels (antiangiogenic effect), said one of the scientific team members here on Tuesday.
This development is considered significant given the limited applicability of platinum drugs, currently the main treatment option for many types of cancer, due to the fast resistance developed by the patients.
The study was jointly conducted by a team comprising Tifr’s Malay Patra, Manikandan M., Sushanta Chhatar, Shubhankar Gadre, Ari’s Chinmay Patra and Gourav Chakraborty, and Iit-Hyderabad’s Naushad Ahmed.
Malay Patra told Ians said that the new therapeutic agent, ‘Ruthenium-Ferrocene Bimetallic’, has the potential to curb primary tumour growth through antiproliferation (use for inhibiting cell growth) and checking metastasis (growth) through antiangiogenesis,...
This development is considered significant given the limited applicability of platinum drugs, currently the main treatment option for many types of cancer, due to the fast resistance developed by the patients.
The study was jointly conducted by a team comprising Tifr’s Malay Patra, Manikandan M., Sushanta Chhatar, Shubhankar Gadre, Ari’s Chinmay Patra and Gourav Chakraborty, and Iit-Hyderabad’s Naushad Ahmed.
Malay Patra told Ians said that the new therapeutic agent, ‘Ruthenium-Ferrocene Bimetallic’, has the potential to curb primary tumour growth through antiproliferation (use for inhibiting cell growth) and checking metastasis (growth) through antiangiogenesis,...
- 1/3/2023
- by News Bureau
- GlamSham
IMDb.com, Inc. takes no responsibility for the content or accuracy of the above news articles, Tweets, or blog posts. This content is published for the entertainment of our users only. The news articles, Tweets, and blog posts do not represent IMDb's opinions nor can we guarantee that the reporting therein is completely factual. Please visit the source responsible for the item in question to report any concerns you may have regarding content or accuracy.